Status Topic selection
Technology type Medicine
Decision Awaiting decision
ID number 6496

Provisional Schedule

Invitation to participate 19 July 2025
Committee meeting: 1 15 October 2025
Expected publication 04 March 2026

Project Team

Project lead Kate Moore
External Assessment Group School of Health and Related Research (ScHARR), University of Sheffield

Stakeholders

Companies sponsors Deciphera Pharmaceuticals (ripretinib)
Others Department of Health and Social Care
  NHS England
Patient carer groups AMMF - The Cholangiocarcinoma Charity
  Black Health Agency for Equality
  Bladder and Bowel Community
  Bowel Cancer Information
  Bowel Cancer UK
  Cancer Black Care
  Cancer52
  GIST Cancer UK
  Guts UK
  Helen Rollason Cancer Charity
  IA: Ileostomy and Internal Pouch Association
  Independent Cancer Patients Voice
  Macmillan Cancer Support
  Maggie’s Centres
  Marie Curie
  Ochre
  Oesophageal Patients Association
  PAWS-GIST Clinic
  OG Support
  Sarcoma UK
  South Asian Health Foundation
  Specialised Healthcare Alliance
  Tenovus Cancer Care
Professional groups Association of Cancer Physicians
  Association of Coloproctology of Great Britain and Ireland
  Association of Upper Gastrointestinal Surgeons of Great Britain and Ireland
  British Geriatrics Society
  British Institute of Radiology
  British Psychosocial Oncology Society
  British Sarcoma Group
  British Society of Gastroenterology
  Cancer Research UK
  Primary Care Society for Gastroenterology
  Royal College of General Practitioners
  Royal College of Nursing
  Royal College of Pathologists
  Royal College of Physicians
  Royal College of Radiologists
  Royal Pharmaceutical Society
  Royal Society of Medicine
  Scottish Sarcoma Network
  Society and College of Radiographers
  UK Clinical Pharmacy Association
  UK Oncology Nursing Society
Associated public health groups Public Health Wales
  UK Health Security Agency
General commentators All Wales Therapeutics and Toxicology Centre
  Allied Health Professionals Federation
  Board of Community Health Councils in Wales
  British National Formulary
  Care Quality Commission
  Department of Health - Northern Ireland
  Healthcare Improvement Scotland
  Medicines and Healthcare products Regulatory Agency
  National Association of Primary Care
  National Pharmacy Association
  NHS Confederation
  NHS Wales Joint Commissioning Committee
  Scottish Medicines Consortium
  Welsh Government
Relevant research groups Bowel Research UK
  Cochrane Upper Gastrointestinal and Pancreatic Diseases Group
  Foundation for Liver research
  GASTROCAN
  Genomics England
  Institute of Cancer Research
  MRC Clinical Trials Unit
  National Institute for Health and Care Research

Timeline

Key events during the development of the guidance:

Date Update
17 March 2025 Invitation to participate
27 January 2025 - 25 February 2025 Consultation on suggested remit, draft scope and provisional stakeholder list of consultees and commentators

For further information on how we select topics for development, please see our page about topic selection